28.11
price down icon0.65%   -0.185
after-market Handel nachbörslich: 28.12 0.005 +0.02%
loading

Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
12.08%
10.79
9.626 9.419 7.357 6.845
Operating Expenses
4.60%
21.67
20.72 19.36 18.89 17.80
Benefits Costs and Expenses
0.81%
19.98
19.82 18.24 17.77 16.46
Costs And Expenses
0.81%
19.98
19.82 18.24 17.77 16.46
Operating Income/Loss
1.89%
-10.88
-11.09 -9.941 -11.53 -10.96
Nonoperating Income/Loss
88.49%
1.687
0.895 1.123 1.121 1.343
Income/Loss From Continuing Operations Before Tax
9.83%
-9.196
-10.20 -8.818 -10.41 -9.613
Income Tax Expense/Benefit
-
- - -0.076 -
Income/Loss From Continuing Operations After Tax
9.83%
-9.196
-10.20 -8.818 -10.34 -9.613
Net Income/Loss
9.83%
-9.196
-10.20 -8.818 -10.34 -9.613
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
65.70%
12.69
7.6559 7.5063 0.1768 6.3514
Diluted Average Shares
65.70%
12.69
7.6559 7.5063 0.1768 6.3514
Basic Earnings Per Share
45.86%
-0.72
-1.33 -1.17 -1.57 -1.51
Diluted Earnings Per Share
45.86%
-0.72
-1.33 -1.17 -1.57 -1.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):